Magstim

🎉 We’re thrilled to be at the Royal College of Psychiatrists International Congress 2024! 🎉 Come and visit the Magstim team at our stand on the 28th & 29th of November to explore how our innovative TMS technology is supporting clinicians and improving patient outcomes. 💡 🧠 Whether you're interested in cost-effective transcranial magnetic stimulation (TMS), streamlined workflows, or our UK-based support services, we’re here to answer your questions and discuss how Magstim can enhance your practice. 📍 If you’re attending, we’d love to connect! Stop by for a chat with Derin Rose & Karen Wendt. #RoyalCollegeOfPsychiatrists #TMS #MentalHealthInnovation #Magstim #Neurotechnology

Watch now! Live TMS webinar for Magstim INSPIRE system workflow. The video recording from Nov 20 TMS webinar is now streaming on YouTube. THANK YOU to all who joined and for your great questions! This webinar shares the workflow for the Horizon Inspire, a new FDA-cleared Transcranial Magnetic Stimulation (TMS) for clinical treatment of MDD, OCD and decreasing Anxious Depression symptoms*. The Horizon Inspire is a next-generation, compact TMS system offering physicians, nurse practitioners and medical professions an easy to use, affordable system for effective treatments. Ideal for practices starting a new TMS treatments to support patient care to grow business revenue. * The Horizon Inspire is a configuration of the Horizon 3.0 TMS therapy system. The FDA has previously cleared the Magstim Horizon 3.0 TMS Therapy System for the treatment of depressive episodes for decreasing anxiety symptoms for those who may exhibit comorbid anxiety symptoms in adult patients suffering from Major Depressive Disorder (MDD) - also known as Anxious Depression. #TMS #depression #psychiatry #OCD Click here to watch: https://lnkd.in/gqDnHWYH Learn more at https://lnkd.in/gytY6t9w

Exciting New TMS Research: Transcranial direct current stimulation with repetitive transcranial magnetic stimulation effective for depression Study states: "Evidence Rating Level: 1 (Excellent) Noninvasive brain-stimulation techniques such as repetitive transcranial magnetic stimulation (rTMS) and transcranial direct current stimulation (tDCS) have each been found to be effective in treating depression when applied individually. However, it remains unclear whether the combination of rTMS and tDCS offers greater efficacy in treating major depressive disorder (MDD). This study thus examined the efficacy and safety of rTMS and tDCS, both individually and in combination, in patients with MDD. This double-blind, sham-controlled randomized clinical trial included adults aged 18-65 diagnosed with MDD from three hospitals in China." Study further states: "Overall, this study found that the combination of tDCS + rTMS was safe and had greater efficacy in reducing depressive symptoms in participants with MDD than tDCS + rTMS alone. Future studies are needed to confirm study findings and elucidate the mechanisms underlying the synergistic effect tDCS + rTMS." Study states: "We used a Magstim Rapid stimulator (Magstim Ltd) for the rTMS treatment, with all patients receiving 10-Hz stimulation via a figure-8 coil on the left DLPFC. Each session included 40 trains (1600 pulses) with 4-second intervals and 26-second intertrain breaks. Treatments were delivered at 110% resting motor threshold from Monday through Friday for 2 weeks. Sham stimulation treatments were performed using a pseudostimulation coil (Coil-D70air film; Magstim Ltd). This coil was placed on the left DLPFC and emitted only sound without stimulation." Thank you to Physician's Weekly for featuring this study published in JAMA Network Open #depression #tDCS #tms https://lnkd.in/gjg_XXJB

Friday TMS video inspiration from U.S. Department of Veterans Affairs team working to improve lives for veterans worldwide. The Magstim team was honored to work with the amazing VA video production team to share this technology. #TMS #depression #veterans #mentalhealth https://lnkd.in/guSbHjBM

Exciting New Product Launch Announcement! For over 30 years, Magstim has supported the UK NHS and UK Clinics with innovative solutions to improve patients’ mental health with non-invasive TMS Treatment. UK Product Launch date: 27th November 2024!   ✅ 30 Years NHS trusted supplier ✅ UK Manufactured ✅ UK Support and Service ✅ Committed to innovation   Keep up to date with Magstim and let us inspire you with the future of neuromodulation! www.magstim.com #Magstim #HorizonInspire #ProductLaunch #InnovationInHealthcare #Neuromodulation

New TMS research report and video: Targeted Magnetic Stimulation Slows Alzheimer's Progression in Phase II Study— Neuro-navigated repetitive TMS in the precuneus slowed progression in mild-to-moderate disease Thank you to MedPage Today for sharing this important research. Article states,"A personalized transcranial magnetic stimulation (TMS) protocol, designed to stimulate the precuneus within the default mode network, was well tolerated and significantly slowed clinical decline in patients with mild-to-moderate Alzheimer's disease, according to data presented at the Clinical Trials on Alzheimer's Disease (CTAD) annual meeting in Madrid." #TMS #Alzheimers #brain https://lnkd.in/gKhxytWC

LIVE TMS Webinar Wednesday. RSVP today to save your spot as few spaces remaining to learn patient workflow for new powerful portable cost effective Magstim INSPIRE TMS. 12 Noon EST Nov 20. click here to RSVP: https://lnkd.in/gncy4773 #depression #mentalhealth #nursepractitioner #psychiatry

LIVE TMS webinar happening Wednesday Nov 20 at 12 Noon EST. See and learn patient workflow for next generation powerful portable cost effective Magstim INSPIRE TMS system. Click here to RSVP and save your spot: https://lnkd.in/gncy4773 #tms #depression #psychiatry #nurse #NP

🎉 Huge congratulations to Jamie Robertson, our dedicated Product Service Support Specialist, on an incredible 25 years of service at Magstim! 🎉 Jamie’s hard work, expertise, and unwavering commitment have been invaluable to our team and the countless clients he's supported over the years. His deep knowledge of our products and his problem-solving skills are second to none, making him an essential part of our Magstim family. Thank you, Jamie, for your dedication and passion over the past quarter of a century. Here's to many more years of success and innovation together! 🥂 #MagstimFamily #MilestoneAnniversary

Thank you to the Psychiatric Times team and Leah Kuntz for sharing news about the #FDA clearance for the Magstim Inspire TMS system. The Magstim team is honored to design and build technologies to help improve patient outcomes. #depression #tms #OCD #psychiatry https://lnkd.in/gpZPHb9A